BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 2816959)

  • 1. Stability of extemporaneously compounded spironolactone suspensions.
    Mathur LK; Wickman A
    Am J Hosp Pharm; 1989 Oct; 46(10):2040-2. PubMed ID: 2816959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid.
    Levinson ML; Johnson CE
    Am J Hosp Pharm; 1992 Jan; 49(1):122-5. PubMed ID: 1570852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of an extemporaneously compounded terbutaline sulfate oral liquid.
    Horner RK; Johnson CE
    Am J Hosp Pharm; 1991 Feb; 48(2):293-5. PubMed ID: 2003504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of isradipine in an extemporaneously compounded oral liquid.
    MacDonald JL; Johnson CE; Jacobson P
    Am J Hosp Pharm; 1994 Oct; 51(19):2409-11. PubMed ID: 7847406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of famotidine in an extemporaneously prepared oral liquid.
    Quercia RA; Jay GT; Fan C; Chow MS
    Am J Hosp Pharm; 1993 Apr; 50(4):691-3. PubMed ID: 8470686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of flecainide acetate in an extemporaneously compounded oral suspension.
    Wiest DB; Garner SS; Pagacz LR; Zeigler V
    Am J Hosp Pharm; 1992 Jun; 49(6):1467-70. PubMed ID: 1529992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of atenolol in an extemporaneously compounded oral liquid.
    Garner SS; Wiest DB; Reynolds ER
    Am J Hosp Pharm; 1994 Feb; 51(4):508-11. PubMed ID: 8017418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of 1% rifampin suspensions prepared in five syrups.
    Krukenberg CC; Mischler PG; Massad EN; Moore LA; Chandler AD
    Am J Hosp Pharm; 1986 Sep; 43(9):2225-8. PubMed ID: 3766578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of spironolactone in an extemporaneously prepared suspension at two temperatures.
    Nahata MC; Morosco RS; Hipple TF
    Ann Pharmacother; 1993 Oct; 27(10):1198-9. PubMed ID: 8251687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of acetazolamide in suspension compounded from tablets.
    Alexander KS; Haribhakti RP; Parker GA
    Am J Hosp Pharm; 1991 Jun; 48(6):1241-4. PubMed ID: 1858804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and stability of diazepam suspension compounded from tablets.
    Strom JG; Kalu AU
    Am J Hosp Pharm; 1986 Jun; 43(6):1489-91. PubMed ID: 3728485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of pediatric liquid dosage forms of ethacrynic acid, indomethacin, methyldopate hydrochloride, prednisone and spironolactone.
    Das Gupta V; Gibbs CW; Ghanekar AG
    Am J Hosp Pharm; 1978 Nov; 35(11):1382-5. PubMed ID: 568384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of aqueous suspensions of disulfiram.
    Das Gupta V
    Am J Hosp Pharm; 1981 Mar; 38(3):363-4. PubMed ID: 7223750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of allopurinol and of five antineoplastics in suspension.
    Dressman JB; Poust RI
    Am J Hosp Pharm; 1983 Apr; 40(4):616-8. PubMed ID: 6846371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of 5-aminosalicylic acid suspension.
    Montgomery HA; Smith FM; Scott BE; White SJ; Gerald KB
    Am J Hosp Pharm; 1986 Jan; 43(1):118-20. PubMed ID: 3953581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of ursodiol in an extemporaneously compounded oral liquid.
    Johnson CE; Nesbitt J
    Am J Health Syst Pharm; 1995 Aug; 52(16):1798-1800. PubMed ID: 8528836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of tacrolimus in an extemporaneously compounded oral liquid.
    Jacobson PA; Johnson CE; West NJ; Foster JA
    Am J Health Syst Pharm; 1997 Jan; 54(2):178-80. PubMed ID: 9117806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of ciprofloxacin in an extemporaneous oral liquid dosage form.
    Johnson CE; Wong DV; Hoppe HL; Bhatt-Mehta V
    Int J Pharm Compd; 1998; 2(4):314-7. PubMed ID: 23989641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of procainamide hydrochloride in an extemporaneously compounded oral liquid.
    Metras JI; Swenson CF; McDermott MP
    Am J Hosp Pharm; 1992 Jul; 49(7):1720-4. PubMed ID: 1621730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.